Delivery Order SPE2DB22D1017-SPE2DB24FG4FY
Award Date
8/30/24
Potential Completion Date
9/23/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corporation for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. The contract has a ceiling value of $12,960.30 and an ultimate completion date of September 3, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for delivering the pharmaceutical product to support the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VYNDAMAX 61 MG Capsule UD 30S, a pharmaceutical product. The contract has a firm fixed-price of $12,960.30 and an ultimate completion date of August 23, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. This delivery order is likely...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a ceiling value of $13,846.97 and is a firm fixed price, non-set-aside contract. The period of performance extends through May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a ceiling value of $25,920.62 and an ultimate completion date of September 4, 2024. It is a firm fixed-price contract and is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide the required medication to support the healthcare needs of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The ceiling value of the delivery order is $12,960.30, and it has a firm fixed price pricing type. The period of performance runs from the award date of September 10, 2024, through October 1, 2024. This delivery order is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription drug product. The contract, which is not set aside, has a ceiling value of $12,960.30 and a period of performance ending on September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of essential medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $13,846.97 and a performance period through May 9, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of December 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a ceiling value of $13,846.97 and is a firm fixed-price delivery order with a period of performance ending on July 14, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication, at a ceiling value of $12,960.30. The contract is a firm-fixed-price delivery order, with an ultimate completion date of October 15, 2024. The contract is not set aside for any specific business designation. AmerisourceBergen Drug Corp, through its corporate...